Reistone Biopharma Alternatives & Competitors

12 companies similar to Reistone Biopharma — Focusing on rapidly developing innovative medicines through global collaboration...

Reviva Pharmaceuticals

Next Generation Therapeutics to successfully address central nervous system, metabolic and...

18 Post-IPO Equity

Cupertino, United States

Biopharma Biotechnology +2

Ultragenyx

Going Beyond Every Day

1535 Post-IPO Equity $1.14B

Novato, United States

Biotechnology Health Care +1

PaxMedica, Inc.

Empowering Possibilities, Transforming Lives: PaxMedica's Journey in Neurodevelopmental So...

7 Post-IPO Equity $30.68M

Tarrytown, United States

Biotechnology Pharmaceutical

Realm Therapeutics, Inc.

2 Post-IPO Equity $26.00M

Malvern, United States

Biotechnology Pharmaceutical

Track all Reistone Biopharma competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

ArriVent Biopharma

Accelerating the Global Development of Innovative Biopharmaceutical Products

79 IPO $564.00M

Biotechnology Life Sciences +1

Theratechnologies Inc.

Health innovation that matters | #HIV #NASH #Oncology

98 Post-IPO Equity $216.26M

Montreal, Canada

Biotechnology Pharmaceutical

CytoAgents, Inc

Calming the Cytokine Storm, Rebalancing the Immune System. Accessible treatment for mult...

10 Series A $22.60M

Pittsburgh, United States

Biotechnology Health Care +1

Adlai Nortye

Pioneering the future of oncology with innovative drug development across the globe.

51-200 Post-IPO Equity $293.00M

Biotechnology Health Care +1

Silver Creek Pharmaceuticals

Rescue cells. Change lives.

12 Venture round $29.15M

South San Francisco, Unit...

Biotechnology Health Care +2

Atea Pharmaceuticals, Inc

Discovery & development of breakthrough therapies for COVID-19 patients and severe viral d...

58 IPO $283.40M

Boston, United States

Biopharma Biotechnology +2

Armetheon

San Francisco Bay-based clinical stage biopharmaceutical company dedicated to pioneering n...

11-50 Series B $31.30M

Biopharma Biotechnology +1

IXALTIS SA

DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS

2 Venture round $8.00M

Toulouse, France

Biopharma Biotechnology +4

About Reistone Biopharma

Reistone Biopharma is a clinical stage biopharmaceutical company founded in 2018. The company's slogan "Focusing on rapidly developing innovative medicines through global collaborations within Research and Development" underlines its commitment to developing novel medicines for life-threatening autoimmune diseases. Wit...

Taxonomy

Biopharmaceutical, R&D, Innovative Medicines, Global Collaborations, Clinical Stage, Autoimmune Diseases, Therapies Development, Unmet Medical Needs, Pharmaceutical Industry, Regulatory Collaboration, Patient Groups, Drug Development, China, Global Impact

Frequently Asked Questions

Companies similar to Reistone Biopharma include Reviva Pharmaceuticals, Ultragenyx, PaxMedica, Inc., Realm Therapeutics, Inc., ArriVent Biopharma. They work in Biotechnology and Pharmaceutical and share Reistone Biopharma's focus on drug development, unmet medical needs and biopharmaceutical.

Bounce Watch lists 12 companies that share Reistone Biopharma's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Reistone Biopharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Reistone Biopharma Profile Ultragenyx Alternatives ArriVent Biopharma Alternatives Atea Pharmaceuticals, Inc Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Reistone Biopharma on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.